Published
Have you wondered why some therapies are swiftly approved by the FDA while others are not? Why does the development of certain treatments succeed while others fail? What reforms are needed to ensure therapies are made available faster?
Learn the answers to these questions by watching this edition of the MDA Advocacy Institute: Unlocking Treatment Development for Rare Neuromuscular Diseases
Learn the answers to these questions by watching this edition of the MDA Advocacy Institute: Unlocking Treatment Development for Rare Neuromuscular Diseases
- Category
- Health
Be the first to comment
-
02:53
FDA Commissioner Robert M. Califf on generating advocacy for rare diseases
-
29:04
Beyond Rare: Bridging the Gap of Rare Disease Knowledge | Rare Diseases Day 2024
-
57:50
Drug Development for Rare Diseases: A Community Conversation
-
57:10
Rare Diseases are Not Rare – A Training on Rare Disease Resources
-
00:17
Patient Advocacy in Accessing and Understanding Rare Disease Treatments
-
4:49:41
Advancing the Development of Therapeutics Through Rare Disease Patient Community Engagement
-
00:17
Unlocking Wellness: Comprehensive Treatment Strategies for All Types of Diseases|#StarWazaifOfficial
-
00:17
Patient Advocacy in Accessing and Understanding Rare Disease Treatments
-
54:19
New Developments and Treatment in Neuromuscular Diseases | UPMC Children's
-
59:51
Rare Disease Patient Registries: Key to Drug Development and Access
-
03:19
Jowar Khichdi Recipe | Healthy & Yummy | Gluten Free Weight Loss Millet Recipes | Culinary Aromas
-
08:07
৭ দিনে যৌন ক্ষমতা বাড়ানোর কুরআনী চিকিৎসা/ Treatment of metal corrosion disease in Bangla
-
00:12
Healthy Lifestyle
